Presence of carcinoma in situ and high 2c-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt

Urology ◽  
2000 ◽  
Vol 55 (3) ◽  
pp. 363-367 ◽  
Author(s):  
B.W.G van Rhijn ◽  
H.G van der Poel ◽  
M.E Boon ◽  
F.M.J Debruyne ◽  
J.A Schalken ◽  
...  
Keyword(s):  
High Risk ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
Deviation Index ◽  
Carcinoma Of The Bladder ◽  
Invasive Transitional Cell Carcinoma

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER:

2000 ◽  
pp. 1124-1129 ◽  
Author(s):  
DONALD L. LAMM &NA; &NA; ◽  
BRENT A. BLUMENSTEIN ◽  
JOHN D. CRISSMAN ◽  
JAMES E. MONTIE ◽  
JAMES E. GOTTESMAN ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
Bacillus Calmette Guerin ◽  
Carcinoma Of The Bladder

Bacillus Calmette–Guérin (BCG) Immunotherapy for Recurrent Noninvasive Transitional Cell Carcinoma of the Bladder

2021 ◽  
pp. 135-140
Author(s):  
Vikram M. Narayan
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
High Grade ◽  
Bacillus Calmette Guerin ◽  
Urothelial Cell Carcinoma ◽  
Carcinoma Of The Bladder ◽  
Disease Specific

This study summarizes the landmark study assessing the value of maintenance intravesical Bacillus Calmette Guerin (BCG) to reduce the risk for recurrence or progression of high-grade superficial or carcinoma in situ (CIS) transitional cell carcinoma of the bladder. The trial randomized patients with completely resected noninvasive urothelial cell carcinoma at high risk of recurrence to BCG induction alone versus BCG induction plus maintenance therapy in the form of six weekly treatments. The study found that maintenance BCG reduces disease-specific recurrence and may also reduce the rate of disease progression.

Cyclooxygenase-2 is Highly Expressed in Carcinoma in Situ and T1 Transitional Cell Carcinoma of the Bladder

2003 ◽  
Vol 169 (3) ◽  
pp. 938-942 ◽  
Author(s):  
SHAHROKH F. SHARIAT ◽  
JA-HONG KIM ◽  
GUSTAVO E. AYALA ◽  
KIMBERLY KHO ◽  
THOMAS M. WHEELER ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
Cyclooxygenase 2 ◽  
Carcinoma Of The Bladder

Hypermethylation of an E-Cadherin ( CDH 1) Promoter Region in High Grade Transitional Cell Carcinoma of the Bladder Comprising Carcinoma In Situ

2003 ◽  
Vol 169 (4) ◽  
pp. 1541-1545 ◽  
Author(s):  
YOHEI HORIKAWA ◽  
KOKICHI SUGANO ◽  
MASANORI SHIGYO ◽  
HIDENOBU YAMAMOTO ◽  
MASAAKI NAKAZONO ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Promoter Region ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
High Grade ◽  
Carcinoma Of The Bladder ◽  
E Cadherin
Sign in / Sign up

Export Citation Format

Share Document